---
title: "Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299049154.md"
description: "ViiV Healthcare, a leading HIV company owned by GSK and Shionogi, revealed over $33 million in community grants for the U.S. in 2026. This funding will aid 230 organizations in 110 cities across 36 states and territories, including Puerto Rico. The grants aim to assist populations most affected by HIV, providing crucial support services."
datetime: "2026-09-15T12:04:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299049154.md)
  - [en](https://longbridge.com/en/news/299049154.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299049154.md)
generator: "portal-rs"
---

# Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.

ViiV Healthcare, a leading HIV company owned by GSK and Shionogi, revealed over $33 million in community grants for the U.S. in 2026. This funding will aid 230 organizations in 110 cities across 36 states and territories, including Puerto Rico. The grants aim to assist populations most affected by HIV, providing crucial support services.

### Related Stocks

- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [SGIOY.US](https://longbridge.com/en/quote/SGIOY.US.md)
- [4507.JP](https://longbridge.com/en/quote/4507.JP.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)

## Related News & Research

- [Gates Foundation extends funding for AN2 Therapeutics-GSK TB drug research collaboration](https://longbridge.com/en/news/300292719.md)
- [HUTCHMED launches first-in-human global trial of novel KRAS-EGFR cancer therapy HMPL-A830](https://longbridge.com/en/news/300234043.md)
- [FACTBOX-Major drugmakers turn to China for licensing deals](https://longbridge.com/en/news/300571193.md)
- [Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Grows By 797.8%](https://longbridge.com/en/news/298662387.md)
- [FACTBOX-Major drugmakers turn to China for licensing deals](https://longbridge.com/en/news/300777907.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**